Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44

Therapeutics for actively targeting over-expressed receptors are of great interest because the majority of diseased tissues originate from normal cells and do not possess a unique receptor from which they can be differentiated. One such receptor is CD44, which has been shown to be highly overexpress...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Giau Van Vo, Kummara Madhusudana Rao, Ildoo Chung, Chang-Sik Ha, Seong Soo A. An, Yang H. Yun
Format:	Article
Language:	English
Published:	MDPI AG 2024-06-01
Subjects:	hyaluronan resveratrol brain tumor CD44
Online Access:	https://www.mdpi.com/1999-4923/16/6/836